About this trial
In this bi-directional program of education, training and research activities based on sustainable development goals aim is to develop cardiac surgery service in Ethiopia.
The aim is to evaluate the short and long-term outcome of cardiac surgery for rheumatic heart disease in a low-income country compared to individuals not offered cardiac surgery due to limited availability of the service. Second aim is to evaluate the quality of anticoagulant therapy in patients after cardiac surgery for rheumatic heart disease in a low-income country .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cardiac surgery due to rheumatic heart disease at the governmental Black Lion University Hospital during the bi-directional programme of education, training and Research to establish Cardiac surgery service
Disqualifiers
Not willing or able to provide written informed consent
Trial population
Cases: Patients offered Cardiac surgery due to indication symptomatic rheumatic heart disease
Trial design
Case-control
Prospective
Treatments tested in this trial
Cardiac surgery
Procedure/Surgery
Treatment groups
Trial outcomes
Primary outcomes
Short term outcome
Freedom from Death or complication
Other outcomes
Time in therapeutic INR
Time in therapeutic window (anticoagulation)
Mitral valve area by Doppler
Influence of concomitant pathology for Echocardiographic assessment of mitral stenosis
Mitral phenotype in rheumatic heart disease
Influence of mitral valve phenotype with cardiac morphology and complications in untreated rheumatic heart disease patients
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Helse Nord-Trøndelag HF
Lead sponsor
Haukeland University Hospital
Collaborator
Addis Ababa University
Collaborator